Monte Rosa Therapeutics
GLUE
10.17
+0.30
+3.04%
Monte Rosa Therapeutics
US · GLUE
#3350 by market cap
Listed 2021
10.17
+0.30
+3.04%
Live - 5344 symbols - heartbeat 160s ago
· 2026-10-08 09:06
Pre-market
10.02
-1.51%
After-hours
10.00
-1.67%
Overnight
10.14
-0.29%
- Market cap
- 867.64M
- P/E (TTM)i
- -5.81
- P/Bi
- 1.78
- EPSi
- -0.46
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on GLUE?
Anonymous reader poll. Unscientific, not investment advice.
About Monte Rosa Therapeutics
Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
- Founded
- 2019
- CEO
- Dr. Markus Warmuth, M.D.
- Employees
- 150
- Headquarters
- Boston, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- monterosatx.com
Company profile
- Exchange
- US
- Symbol
- GLUE
- Market-cap rank
- #3350
- Listing date
- 2021-06-24
- Market cap
- 867.64M
- Float cap
- 554.02M
- Shares out
- 85.31M
- Float shares
- 54.48M
Sectors & themes
Quote time 2026-10-08 09:06:36 · For reference only, not investment advice and not tailored to your situation.